Cerus - 23 Year Stock Price History | CERS

Historical daily share price chart and data for Cerus since 1997 adjusted for splits. The latest closing stock price for Cerus as of September 22, 2020 is 6.24.
  • The all-time high Cerus stock closing price was 80.50 on December 28, 2000.
  • The Cerus 52-week high stock price is 7.94, which is 27.2% above the current share price.
  • The Cerus 52-week low stock price is 2.71, which is 56.6% below the current share price.
  • The average Cerus stock price for the last 52 weeks is 5.28.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cerus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 5.6283 4.2500 7.4700 2.8700 6.2400 47.87%
2019 5.3073 5.3400 6.8500 3.8400 4.2200 -16.77%
2018 5.9496 3.5600 7.7800 3.5600 5.0700 50.00%
2017 3.3151 4.3300 4.6100 2.0200 3.3800 -22.30%
2016 5.8151 6.2400 7.3900 4.2200 4.3500 -31.17%
2015 5.0900 6.5150 6.5900 3.8600 6.3200 1.28%
2014 4.7555 6.4800 7.9500 3.5000 6.2400 -3.26%
2013 5.0364 3.1900 6.9400 2.9500 6.4500 104.11%
2012 3.3740 2.8600 4.3200 2.7600 3.1600 12.86%
2011 2.7593 2.4800 3.5700 1.9800 2.8000 13.82%
2010 2.8919 1.8000 3.9300 1.7800 2.4600 23.62%
2009 1.4225 0.8200 2.9800 0.6200 1.9900 184.29%
2008 4.3830 6.5600 7.2400 0.5800 0.7000 -89.25%
2007 6.9439 5.6800 10.1800 5.1300 6.5100 11.09%
2006 7.9441 10.0100 14.4800 5.3100 5.8600 -42.27%
2005 5.7493 3.1000 11.3300 3.0500 10.1500 244.07%
2004 2.9397 4.5000 4.7100 1.8500 2.9500 -35.02%
2003 7.4799 21.7200 21.7200 3.4000 4.5400 -78.88%
2002 33.4212 46.7700 58.6800 11.8700 21.5000 -53.01%
2001 55.9461 69.7500 75.3500 33.6300 45.7500 -39.20%
2000 49.3281 24.8800 80.5000 24.8800 75.2500 183.96%
1999 23.9083 20.5000 31.2500 15.4400 26.5000 26.19%
1998 16.4542 22.0000 23.7500 12.0000 21.0000 -4.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.029B $0.075B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $187.588B 35.20
Medtronic (MDT) Ireland $140.874B 26.53
Stryker (SYK) United States $76.056B 29.49
Boston Scientific (BSX) United States $55.153B 31.86
Lonza Group Ag (LZAGY) Switzerland $46.893B 0.00
Baxter (BAX) United States $40.625B 24.85
Terumo (TRUMY) Japan $30.404B 38.86
EssilorLuxottica Societe Anonyme (ESLOY) France $28.134B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.745B 23.02
ResMed (RMD) United States $24.852B 36.03
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.462B 0.00
Bio-Rad Laboratories (BIO) United States $15.371B 69.52
Insulet (PODD) United States $14.743B 623.81
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.390B 44.44
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.267B 10.75
Canopy Growth (CGC) Canada $5.852B 0.00
Hill-Rom Holdings (HRC) United States $5.626B 13.96
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.515B 0.00
Haemonetics (HAE) United States $4.236B 28.23
ICU Medical (ICUI) United States $4.018B 30.66
Neogen (NEOG) United States $3.955B 65.99
Envista Holdings (NVST) United States $3.743B 25.52
Abcam (ABCZY) $3.232B 0.00
TG Therapeutics (TGTX) United States $3.227B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.107B 0.00
National Vision Holdings (EYE) United States $3.004B 466.88
NuVasive (NUVA) United States $2.537B 35.36
Agios Pharmaceuticals (AGIO) United States $2.521B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.901B 173.46
AtriCure (ATRC) United States $1.737B 0.00
NanoString Technologies (NSTG) United States $1.723B 0.00
MacroGenics (MGNX) United States $1.489B 0.00
Cardiovascular Systems (CSII) United States $1.367B 0.00
Aphria (APHA) Canada $1.280B 0.00
InMode (INMD) Israel $1.113B 28.07
Quanterix (QTRX) United States $0.941B 0.00
Owens & Minor (OMI) United States $0.906B 20.30
OraSure Technologies (OSUR) United States $0.905B 0.00
PetIQ (PETQ) United States $0.851B 24.41
BioLife Solutions (BLFS) United States $0.845B 440.00
Lantheus Holdings (LNTH) United States $0.833B 11.55
Meridian Bioscience (VIVO) United States $0.743B 17.16
Aurora Cannabis (ACB) Canada $0.730B 0.00
Phibro Animal Health (PAHC) United States $0.714B 16.35
Vapotherm (VAPO) United States $0.712B 0.00
LeMaitre Vascular (LMAT) United States $0.650B 39.68
Omeros (OMER) United States $0.636B 0.00
Zynex (ZYXI) United States $0.560B 48.91
Eagle Pharmaceuticals (EGRX) United States $0.540B 76.31
Surmodics (SRDX) United States $0.525B 57.61
VAREX IMAGING (VREX) United States $0.461B 19.99
Cytosorbents (CTSO) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.358B 12.79
HEXO (HEXO) $0.343B 0.00
Utah Medical Products (UTMD) United States $0.287B 24.64
Surface Oncology (SURF) United States $0.271B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
InfuSystems Holdings (INFU) United States $0.260B 49.54
Organigram Holdings (OGI) Canada $0.231B 0.00
Female Health (VERU) United States $0.197B 0.00
Chimerix (CMRX) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.172B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.155B 13.76
Exagen (XGN) United States $0.140B 0.00
Liberty Health Sciences (LHSIF) Canada $0.134B 0.00
Evolus (EOLS) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.102B 0.00
Rockwell Medical (RMTI) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.096B 0.00
United-Guardian (UG) United States $0.069B 15.46
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Brainsway (BWAY) Israel $0.064B 0.00
Nephros (NEPH) United States $0.057B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 9.95
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.021B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.019B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00